Inhibition of the dipeptidyl peptidase DPP4 (CD26) reveals IL-33-dependent eosinophil-mediated control of tumor growth.

Nat Immunol 2019 03 18;20(3):257-264. Epub 2019 Feb 18.

Department of Cancer Immunology, Genentech, South San Francisco, CA, USA.

Post-translational modification of chemokines mediated by the dipeptidyl peptidase DPP4 (CD26) has been shown to negatively regulate lymphocyte trafficking, and its inhibition enhances T cell migration and tumor immunity by preserving functional chemokine CXCL10. By extending those initial findings to pre-clinical models of hepatocellular carcinoma and breast cancer, we discovered a distinct mechanism by which inhibition of DPP4 improves anti-tumor responses. Administration of the DPP4 inhibitor sitagliptin resulted in higher concentrations of the chemokine CCL11 and increased migration of eosinophils into solid tumors. Enhanced tumor control was preserved in mice lacking lymphocytes and was ablated after depletion of eosinophils or treatment with degranulation inhibitors. We further demonstrated that tumor-cell expression of the alarmin IL-33 was necessary and sufficient for eosinophil-mediated anti-tumor responses and that this mechanism contributed to the efficacy of checkpoint-inhibitor therapy. These findings provide insight into IL-33- and eosinophil-mediated tumor control, revealed when endogenous mechanisms of DPP4 immunoregulation are inhibited.

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41590-019-0321-5DOI Listing
March 2019
4 Reads

Publication Analysis

Top Keywords

dpp4 cd26
8
anti-tumor responses
8
dipeptidyl peptidase
8
peptidase dpp4
8
tumor control
8
dpp4
5
cancer discovered
4
mechanism contributed
4
mice lacking
4
discovered distinct
4
breast cancer
4
responses mechanism
4
dpp4 improves
4
improves anti-tumor
4
carcinoma breast
4
inhibition dpp4
4
mechanism inhibition
4
distinct mechanism
4
models hepatocellular
4
checkpoint-inhibitor therapy
4

References

(Supplied by CrossRef)

DE Speiser et al.
Nat. Rev. Immunol. 2016

P Proost et al.
Blood 2001

V Vanheule et al.
Cytokine 2018

A Casrouge et al.
J. Clin. Invest. 2011

SY Cho et al.
Cancer Res. 2010

R Barreira da Silva et al.
Nat. Immunol. 2015

CSC Lam et al.
PLoS ONE 2014

PI Liang et al.
Oncotarget 2017

U Yamaguchi et al.
J. Clin. Oncol. 2008

R Carretero et al.
Nat. Immunol. 2015

A Munitz et al.
Allergy. 2004

Similar Publications